ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004

Decline In Breast Cancer Death Explained By Screening, Adjuvant Therapy, Study Finds

November 25, 2005

Bonner to Succeed Stovall as NCCS President and CEO.

May 30, 2008

One In 8 Survivors Report Suicidal Thoughts, Attempts

August 25, 2006

Growth in Research Capacity Explains Increased Competition, NIH Director Tells NCAB.

June 16, 2006

ASTRO Announces Election Results, Staff Restructuring

September 17, 2010